Loading...
Time from first dose of study drug to first radiographic disease progression or death, whichever occurs first
Advent event rate
Proportion of subjects with complete response (CR) and partial response (PR) to total subjects; including assessment of irradiated lesions and non-irradiated lesions
The time from the start of treatment to death
Proportion of total subjects defined as complete response (CR), partial response (PR), and stable disease (SD)
The time from when the tumor is first evaluated as CR or PR to when the tumor is first evaluated as PD (Progressive Disease) or death from any cause